(Q74044354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

editorial

0 references

title

Tamoxifen for early breast cancer: better late than never (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

C Davies

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Perry

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

505-507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Delayed adjuvant tamoxifen: ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Preliminary Results From the Cancer Research Campaign Trial Evaluating Tamoxifen Duration in Women Aged Fifty Years or Older With Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Five years of tamoxifen--or more?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Adjuvant tamoxifen: how long before we know how long?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008323116265

7 January 2021

Identifiers

DOI

10.1023/A:1008323116265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10907940%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference